However, studies have also shown that METTL3 can induce the m6A mRNA modification of TCF1, a downstream effector of the classical Wnt pathway encoded by TCF7, by activating the Wnt pathway, thereby accelerating the progression of thyroid cancer (Wang et al., 2020c). This evidence concerns the gene TCF7 and thyroid cancer.